Pain and Inflammation Research

Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.

Pain and Inflammation Research Products Areas

Products for Pain and Inflammation Research - Page 86

  1. Cat.No. Product Name Information/Activity
  2. BCC6156 MNI 137 946619-21-2 MNI 137 chemical structure
  3. BCC7866 Xanthurenic acid Xanthurenic acid is a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus. Xanthurenic acid chemical structure
  4. BCC1487 Clozapine N-oxide (CNO) Activator of muscarinic DREAADs,Clozapine N-oxide is a pharmacologically inert metabolite of Clozapine, which is a potent <b>5-HT1C</b> receptor antagonist. Clozapine N-oxide (CNO) chemical structure
  5. BCC5702 ACPT-I 194918-76-8 ACPT-I chemical structure
  6. BCC7344 AMN 082 dihydrochloride The first selective mGlu<sub>7</sub> agonist AMN 082 dihydrochloride chemical structure
  7. BCC6550 L-AP4 L-APB is a potent and specific agonist for the group III mGluRs, with EC50s of 0.13, 0.29, 1.0, 249 μM for mGlu4, mGlu8, mGlu6 and mGlu7 receptors, respectively. L-AP4 chemical structure
  8. BCC7865 Cinnabarinic acid 606-59-7 Cinnabarinic acid chemical structure
  9. BCC7045 (RS)-3,4-DCPG 176796-64-8 (RS)-3,4-DCPG chemical structure
  10. BCC7012 (S)-3,4-DCPG 201730-11-2 (S)-3,4-DCPG chemical structure
  11. BCC7652 NPEC-caged-(S)-3,4-DCPG 1257323-85-5 NPEC-caged-(S)-3,4-DCPG chemical structure

Items 851 to 860 of 1162 total